Although DPP-4 inhibitors are known to have favorable effects on cardiovascular disease, such as aortic aneurysm and stroke [8, 9], the effect of DPP-4 inhibitors on myocarditis has not been investigated. This evidence concerns the gene DPP4 and cardiovascular disorder.